mRNA |
lapatinib |
gCSI |
pan-cancer |
AAC |
0.14 |
0.01 |
mRNA |
SN-38 |
GDSC1000 |
pan-cancer |
AAC |
-0.083 |
0.01 |
mRNA |
MLN4924 |
CTRPv2 |
pan-cancer |
AAC |
-0.081 |
0.02 |
mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.02 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
Gemcitabine |
GDSC1000 |
pan-cancer |
AAC |
-0.082 |
0.02 |
mRNA |
Doxorubicin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.02 |
mRNA |
navitoclax:piperlongumine (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.083 |
0.02 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.073 |
0.02 |
mRNA |
selumetinib:JQ-1 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.079 |
0.02 |